17-18263105-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139162.4(MIEF2):c.167G>A(p.Ser56Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000265 in 1,613,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139162.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIEF2 | NM_139162.4 | c.167G>A | p.Ser56Asn | missense_variant | 3/4 | ENST00000323019.9 | NP_631901.2 | |
MIEF2 | NM_148886.2 | c.200G>A | p.Ser67Asn | missense_variant | 3/4 | NP_683684.2 | ||
MIEF2 | NM_001144900.3 | c.167G>A | p.Ser56Asn | missense_variant | 3/4 | NP_001138372.1 | ||
MIEF2 | XM_017024190.2 | c.188G>A | p.Ser63Asn | missense_variant | 3/4 | XP_016879679.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIEF2 | ENST00000323019.9 | c.167G>A | p.Ser56Asn | missense_variant | 3/4 | 2 | NM_139162.4 | ENSP00000323591.4 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250864Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135724
GnomAD4 exome AF: 0.000274 AC: 401AN: 1461066Hom.: 0 Cov.: 32 AF XY: 0.000272 AC XY: 198AN XY: 726814
GnomAD4 genome AF: 0.000177 AC: 27AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 02, 2024 | The c.200G>A (p.S67N) alteration is located in exon 3 (coding exon 3) of the MIEF2 gene. This alteration results from a G to A substitution at nucleotide position 200, causing the serine (S) at amino acid position 67 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at